net dbt
afternoon announc sign agreement depart
veteran affair modern va current electron health record contract
contract question given chang va leadership well recent market
nois around on-going depart defens roll-out earli detail light
although fund alloc congress project
act va secretari robert wilki note previous mention ceil
year manag also note sign contract
contempl time contract provid visibl full year
guidanc admittedli reduc due contract delay
matter binari natur deal background
va contract complet black box remov former va secretari
david shulkin major propon award threw upheav
time contract whether would actual sign contract
provid level cushion current year estim well
achiev manag long-term target particularli given current
turmoil cern tradit market roll-out contract complic
meaning near-term impact va final give two sizabl
govern contract support long-term growth back agreement
increas price object po given greater visibl
beyond estim new po base price-to-earnings ex-cash
acknowledg near-term challeng base busi
compani strong market posit long-term runway thank dod/va contract
caus us reiter buy rate also still believ clariti around
va ampl opportun expand deploy cash flow
given compani current net cash posit
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
largest stand-alone healthcar
compani sell wide rang softwar
servic hospit physician
product cerner millennium platform
serv base broader solut
offer also sell number addit
servic offer leverag clinic
infrastructur larg instal base
compani base kansa citi
buy rate base market leader
widest rang increment cross-sel
opportun within ever-grow custom
base compani also abl leverag
recent expens provid
increment cash flow appli
valuat overal market growth
slow vs post-american recoveri
reinvest act period see
continu share-gain becom
bifurc competit market
price object base ep estim ex-cash multipl
five-year averag absolut multipl basi well rel
incorpor modest growth slowdown also premium
downsid risk po market paus spend particularli driven
healthcar reform uncertainti increas competit pressur epic system
well newer cloud-bas entiti integr cost associ va
dod contract hamper margin upsid risk would come acceler
cross-sel opportun notabl around popul health revenu upsid va
contract roll-out increas leverag drive improv margin expans potenti
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
